Glaxo Smith Kline Pharmaceuticals Limited Vs Unitech Pharmaceuticals Private Limited

Trademark Act, 1999 – Use of a Trademark which is deceptively similar to another Trademark – whether valid?

Brief facts

The Plaintiff (Glaxo Smith Kline Pharmaceuticals Limited) claimed that the defendants (Unitech Pharmaceuticals Private Limited) are selling products under the Trademark “FEXIM” that is deceptively similar to the Plaintiff ‘s mark “PHEXIN” which is used for Pharmaceutical preparations. The defendants are selling anti-biotic tablets with the Trademark FEXIM” with the packing material deceptively similar to that of Plaintiff.

Decision and reason

Based on the Trademark Act, 1999, the Court restrained the Defendant from using the Trademark FEXIM” or any Trademark deceptively similar to the Trademark of the Plaintiff “PHEXIN”, any label/ packaging  deceptively similar and containing the same pattern as that of the Plaintiff.

© Copyright © 2014 R & A Associates. All rights reserved.Best viewed in Internet Explorer 8

R & A Associates hereby declare that the contents of this website are true to the best of our knowledge and belief and are in conformity with Guidelines for Advertisement by Company Secretary in Practice - Guideline No.4 of 2007 issued by the ICSI. The contents or claims in this website are the sole and exclusive responsibility of R & A Associates. The Institute of Company Secretaries of India does not own any responsibility whatsoever for such contents or claims by the R & A Associates.
powered by Infiniti Techlabs